In another way, compared with high grade serous ovarian cancer, most clear-cell ovarian cancers are characterized by considerably fewer copy number alterations, and mutations in TP53 and BRCA1/BRCA2 genes are uncommon [51]. This evidence concerns the gene BRCA1 and ovarian serous adenocarcinoma.